Market Access Views & Analysis

Views & Analysis

Market Access

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.

Market Access

Lori Fletcher and Amber Beimer, Advanced Clinical

Health Innovators: Lori Fletcher and Amber Beimer, Advanced ...

Clinical research is full of challenges, from recruitment to data management to global resourcing.

Market Access

EMA’s strategy for speeding up drug approvals in the EU

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike

Market Access

Looking to history to prepare for America’s uncertain future

In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration

Market Access

Navigating new risks: How China’s Anti-Espionage Law could i...

The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential

Market Access

Metrics for the UK’s VPAG: A work in progress

Just as for previous schemes, metrics are being used to track VPAG, the UK’s voluntary scheme that covers branded medicines pricing and access.

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

Health Innovators: Lori Fletcher and Amber Beimer, Advanced ...

EMA’s strategy for speeding up drug approvals in the EU

Looking to history to prepare for America’s uncertain future

Navigating new risks: How China’s Anti-Espionage Law could i...

Metrics for the UK’s VPAG: A work in progress

Trustworthy and novel AI in clinical trial planning, with Kr...

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks